![Joël Crouzet](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Joël Crouzet
Plus aucun poste en cours
Profil
Joël Crouzet was the founder of Minka Therapeutics SA, serving as Chief Executive & Scientific Officer from 2011 to 2014, founded in 2008.
Dr. Crouzet was the founder of Ermium Therapeutics SAS, serving as Chief Executive Officer, founded in 2019.
Former job at INSERM Transfert SA as Chief Executive Officer.
Former job at Rhone Poulenc Rorer from 1990 to 1996 as Departmental Director.
Former job at NeuroTECH SA as Research Director.
Education includes a doctorate from Institut National Agronomique Paris-Grignon.
Anciens postes connus de Joël Crouzet
| Sociétés | Poste | Fin |
|---|---|---|
INSERM Transfert SA
 INSERM Transfert SA Investment ManagersFinance ITSA is an active private equity investment manager focused exclusively on the French biomedical sector, particularly on areas related to INSERM's medical research effort. They favor projects in fields including therapeutic agents, medical devices, diagnostics, tools and technological platforms. The firm invests between EUR 100 and 300 thousand in pre-seed and seed financing. ITSA's investment criteria include sound science, a driven management team, strong IP, a realistic business model with a clearly defined market, and a competitive milestone-driven schedule. They seek to invest in ambitious projects addressing unmet medical needs and potentially leading to dominant market positions. The firm may act as a co-founder, generally sits on the board of their portfolio companies and actively participates in their strategic decisions. | President | 01/09/2008 |
Rhone Poulenc Rorer
 Rhone Poulenc Rorer Chemicals: SpecialtyProcess Industries Manufactures and distributs pharmaceutical products. | Corporate Officer/Principal | - |
Ermium Therapeutics SAS
 Ermium Therapeutics SAS BiotechnologyHealth Technology Operates as a biotechnology company which develops therapies for auto-immune diseases | Directeur Général | - |
NeuroTECH SA
 NeuroTECH SA Medical SpecialtiesHealth Technology Designs, develops, manufactures, and markets active implantable medical devices | Directeur Technique/Scientifique/R&D | - |
Minka Therapeutics SA
 Minka Therapeutics SA Pharmaceuticals: MajorHealth Technology Develops a portfolio of therapeutic products and diagnostic complementary to current antiretroviral therapy in the treatment of AIDS | Directeur Général | - |
Formation de Joël Crouzet
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
10
Relations au 1er degré
6
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Rhone Poulenc Rorer
Rhone Poulenc Rorer Chemicals: SpecialtyProcess Industries Manufactures and distributs pharmaceutical products. | Process Industries |
INSERM Transfert SA
INSERM Transfert SA Investment ManagersFinance ITSA is an active private equity investment manager focused exclusively on the French biomedical sector, particularly on areas related to INSERM's medical research effort. They favor projects in fields including therapeutic agents, medical devices, diagnostics, tools and technological platforms. The firm invests between EUR 100 and 300 thousand in pre-seed and seed financing. ITSA's investment criteria include sound science, a driven management team, strong IP, a realistic business model with a clearly defined market, and a competitive milestone-driven schedule. They seek to invest in ambitious projects addressing unmet medical needs and potentially leading to dominant market positions. The firm may act as a co-founder, generally sits on the board of their portfolio companies and actively participates in their strategic decisions. | Finance |
Institut National Agronomique Paris-Grignon
 Institut National Agronomique Paris-Grignon Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NeuroTECH SA
NeuroTECH SA Medical SpecialtiesHealth Technology Designs, develops, manufactures, and markets active implantable medical devices | Health Technology |
Minka Therapeutics SA
Minka Therapeutics SA Pharmaceuticals: MajorHealth Technology Develops a portfolio of therapeutic products and diagnostic complementary to current antiretroviral therapy in the treatment of AIDS | Health Technology |
Ermium Therapeutics SAS
Ermium Therapeutics SAS BiotechnologyHealth Technology Operates as a biotechnology company which develops therapies for auto-immune diseases | Health Technology |
